Honasa Consumer Share Price Gains After Q1 FY27 Earnings Results: Total Income Up 25.7% YoY

On August 13, 2026, Honasa Consumer Limited released its unaudited consolidated financial results for the quarter ending June 30, 2026, as per the exchange filings.
The company reported a total income of ₹778.46 crore and net profit of ₹90.45 crore for the quarter ending June 30, 2026.
Honasa Consumer Q1 FY27 Earnings Results
For the quarter ending June 30, 2026, Honasa Consumer Limited's total income increased by 25.7% year-on-year (YoY) to ₹778.46 crore, up from ₹619.14 crore in the same quarter of the previous year.
The company also saw a 15.2% quarter-on-quarter (QoQ) rise from ₹675.96 crore in the March 2026 quarter.
Net profit for the June 2026 quarter rose by 118.9% YoY to ₹90.45 crore, compared to ₹41.33 crore a year ago.
This also marks a 30.3% QoQ increase from ₹69.44 crore in the March 2026 quarter.
Annual Performance for FY26
For the financial year 2026, Honasa Consumer Limited's total income stood at ₹2,475.53 crore. The net profit for the year was recorded at ₹200.19 crore, reflecting the company's strong financial performance over the year.
Margin Drivers and Guidance Trajectory
Management decomposed the quarter’s margin expansion into several structural components. Profitability was aided by product mix optimization, a 100 bps benefit from operating leverage, and a 50 bps seasonal tailwind from higher-margin summer products.
The underlying normalized EBITDA margin sat at roughly 12% after adjusting for a one-time non-recurring operating expenditure benefit. The company reiterated its long-term strategy to expand EBITDA margins by 100–150 bps per year to reach 15% in five years.
Channel Performance and Inventory Health
The core product categories and individual retail channels maintained healthy baseline performance with tightly controlled operational cycles. Prioritized focus categories expanded by 35% or more year-on-year, representing an 85% contribution to total revenues.
Digital platforms recorded an overarching growth rate of 40%+, while general trade secondary growth and modern trade off-take growth both cleared 40%+. Supply chain safety checks reduced distributor inventory to less than 30 days.
Brand Portfolio Highlights
The flagship brand Mamaearth accelerated to high-teens growth during the quarter, driven by strong double-digit momentum in its core Rice and Ubtan franchises. The Rosemary formulation established itself as a major asset, while moisturizers approached a ₹50 crore annualised run rate.
The Derma Co. achieved a critical milestone by becoming the second ₹1,000 crore brand in the portfolio while entering the teens EBITDA club. Concurrently, younger brands registered an aggregate growth rate of 40%+ year-on-year.
Corporate Expansion and Strategic Actions
The company continued executing value creation levers through targeted M&A and new vertical entry. The acquired BTM Ventures male grooming line reached a ₹150 crore ARR, representing almost 100% growth since its acquisition.
A dedicated vehicle named Honasa Health was created to tap into the nutrition and wellness sector. Furthermore, the company launched FICIN, a fine fragrance brand featuring a clinically tested 12-hour long-stay formula.
Read More: Aditya Birla Real Estate Share Price in Focus After Q1 FY27 Earnings Results: Total Income Up 30.7% YoY!
Honasa Consumer Share Price Performance
As of August 14, 2026, at 10:55 AM, Honasa Consumer share price on NSE was trading at ₹489.00, up by 1.99% from the previous closing price.
Conclusion
Honasa Consumer Limited's Q1 2026 results show a 25.7% YoY increase in total income to ₹778.46 crore and a 118.9% YoY rise in net profit to ₹90.45 crore. The company's total income for FY26 was ₹2,475.53 crore, with a net profit of ₹200.19 crore.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Aug 14, 2026, 12:38 PM IST

Team Angel One
- Aurobindo Pharma Share Price in Focus; Receives US FDA Warning Letter to Eugia Pharma Unit-I
- LG Electronics India Share Price Gains Over 8% After Q1 FY27 Earnings Results: Total Income Up 15.6% YoY
- Jubilant FoodWorks Share Price Gains Over 2% After Q1 FY27 Earnings Results: Total Income Up 14% YoY
- Welspun Living Share Price Gains Over 7% After Q1 FY27 Earnings Results: Total Income Up 23.5% YoY
- Indigo Paints Share Price Gains Over 4% After Q1 FY27 Earnings Results: Total Income Up 20.7% YoY


